Scientists Exonerated By ORI Report Lingering Wounds

ALL-CONSUMING: Exonerated researcher Herbert Needleman reports having had "no original ideas" while his case was pending. Those eventually cleared of misconduct charges say the system is too eager to presume them guilty. Approximately 70 percent of cases of alleged scientific misconduct that come to the attention of the Office of Research Integrity (ORI), an arm of the Department of Health and Human Services, end up with the accused being cleared. But what happens to these re- spondents-as OR

Written byBilly Goodman
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share


ALL-CONSUMING: Exonerated researcher Herbert Needleman reports having had "no original ideas" while his case was pending.

Those eventually cleared of misconduct charges say the system is too eager to presume them guilty.
Approximately 70 percent of cases of alleged scientific misconduct that come to the attention of the Office of Research Integrity (ORI), an arm of the Department of Health and Human Services, end up with the accused being cleared. But what happens to these re- spondents-as ORI calls the accused-after they are exonerated? The Scientist interviewed 10 scientists and physicians who had been formally charged with misconduct in scientific research and subsequently cleared of those charges. Most say that the system is too ready to presume them guilty-and that the "exoneration" does not totally obliterate their ordeal from the public consciousness.

The 1996 ORI report, "Survey of Accused but Exonerated Individuals in Research Misconduct Cases,'' reveals that three out ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies